TRANDOLAPRIL-AS trandolapril 2 mg capsule blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

trandolapril, Quantity: 2 mg

Available from:

Medis Pharma Pty Ltd

INN (International Name):

Trandolapril

Pharmaceutical form:

Capsule

Composition:

Excipient Ingredients: sodium stearylfumarate; povidone; maize starch; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; iron oxide yellow; erythrosine; potable water; Gelatin; sodium lauryl sulfate

Administration route:

Oral

Units in package:

28 capsules

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Trandolapril is indicated for the treatment of hypertension. Data to support the usage of trandolapril in renovascular hypertension are, at present, not available. Trandolapril is also indicated for patients with left ventricular dysfunction post myocardial infarction [ejection fraction less than or equal to 35% or WMI (Wall Motion Index) less than or equal to 1.2].

Product summary:

Visual Identification: "Size 4" Orange coloured cap imprinted with 'TR' in black ink and orange coloured body imprinted with '2' in black ink; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2012-10-02